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DIETARY PHOSPHOROUS INTAKE AMONG HAEMODIALYSIS PATIENTS IN
RELATION TO DOSAGE OF PHOSPHATE BINDERS AND
HYPERPHOSPHATEMIA.
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Hyperphosphatemia in haemodialysis (HD) patients is associated with
mineral and bone disorder and increased cardiovascular disease. Despite
dietary restriction of phosphorous (P), improved dialysis therapy and
phosphate binders (PB), hyperphosphatemia remains a serious problem
among the dialysis population. A sub-optimal relationship between the
actual dietary intake of P and the intake of PB’s may be one explanation.
The aim of the present study was to investigate the dietary P intake in a
group of HD patients in relation to the taken dosage of PB, and to establish
what, if any, relationship exists with the patients’ plasma phosphate level.
Self-reported intake of P, assessed by three-day estimated food record, and
intake of PB was analysed in thirty-one adult (age 61.8712.9 years) HD
patients (17 men, 14 women), who were divided into two groups according
to their plasma P levels. The mean dietary P intake among all patients was
12707420 mg/d with a mean day-to-day variation of 3907310 mg. The P
intake in one single meal ranged from o10 mg to 1430 mg, average
2567200 mg. The variation of dosing regimens of PB among the patients
was large (1–4 to 12–16 per day), although each patient’s regimen was
ﬁxed and in most cases was 3 times daily. No signiﬁcant differences
regarding dietary P intake (p¼0.51) nor PB’s (p¼0.41) between patients
with high (41.6 mmol/l) and low (o1.6 mmol/L) plasma P levels were
observed. In conclusion, the ﬁndings show a notable individual day-to-day
and meal-to-meal variation in dietary P intake and in contradiction, the
same individual dosing regimen of PB. Strangely, no signiﬁcant difference
in the dietary P intake or intake of PBs between HD patients with high or
low plasma P level was found. The question of whether a PB intake better
tailored to the meal and day variation in P intake could prevent
hyperphosphatemia will need to be evaluated in further studies.
http://dx.doi.org/10.1016/j.krcp.2012.04.343
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IMPLEMENTING A COMPUTERISED SYSTEM WITH STANDARDISED
LANGUAGE TO ENHANCE EFFICIENCY OF NUTRITION CARE IN A
HEMODIALYSIS POPULATION
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To assess the impact of the implementation of an information technology
system using standardized language (International Dietetic and Nutrition
Terminology, IDNT) on efﬁciency and patient outcomes.
This was a longitudinal study of hemodialysis patients (Z18 years, Z3
months dialysis vintage) at a single facility. During the ﬁrst 6 month period
(months 0–6), patients received usual standard of care, with documentation
via a manual paper-based system. During the following 6–month period
(months 7–12), nutritional care was documented and tracked by a
computerized system incorporating IDNT. Improvement or deterioration in
nutritional status was determined via routine nutritional assessment and
documented using IDNT. Workload efﬁciency was determined using a
Workload Mapping Tool. Difference between systems was assessed using
t-test for continuous and chi-square test for categorical variables.
Ninety-one patients were recruited at baseline, another 12 patients in the
ﬁnal 6 month intervention period (age (SD) 58 years (16), 53% male (n¼55),
vintage 43 months (inter-quartile range, 25 to 75 months), malnutrition by
SGA, 10.9%). Introduction of the computerized system resulted in a higher rate
of resolution of nutritional diagnoses (mean 1.43 (CI 1.19–1.67) compared
with the paper-based system (mean 0.68 (CI 0.49–0.87)) (po0.001). The
number of patients exceeding serum phosphate targets (41.6 mmol/L)
decreased from 73% to 59% with introduction of the new system, and dry
weight change improved (mean difference 1.6% (SD 5.2) (p¼0.025)). There
was no signiﬁcant difference in malnutrition rates (p¼0.586) or inter-dialytic
ﬂuid gains (p¼0.836). Efﬁciency was improved by an average of 13 minutes
per patient per review using the new system (po0.001).
The implementation of a computerized nutrition care process incorporating
IDNT in the hemodialysis population resulted in improved efﬁciency without
compromising nutrition-related outcomes.
http://dx.doi.org/10.1016/j.krcp.2012.04.34421
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After kidney transplantation weight gain is associated with adverse
effects such as hypertension, dyslipidemia, insulin resistance, increased
vascular risk and deterioration of graft function. The identiﬁcation weight
gain mechanisms would be helpful to propose preventive strategies. This
study addressed energy expenditure (EE) changes after kidney
transplantation. Fifteen male patients aged 52.871.7 years, transplanted
for one to 6 years, non-diabetic and with stable renal function (calculated
creatinine clearance, 30–90 ml/min/1.73 m2) were included. They received
anticalcineurin drugs but not corticosteroids. Nine healthy volunteers
matched for age (54.271.9 years) and fat-free mass (FFM) were considered
as controls. Body composition, including FFM, was determined by DEXA. EE
was measured under controlled conditions (24 hours in calorimetric
chambers) during the following activities: sleep, rest, meals, and 2 sessions
of 30 min of treadmill walking (4 and 5 km/h). The EE results are expressed
per kg of FFM, mean 7 SEM. FFM was respectively 62.072.3 and
62.372.7 kg in patients and controls (NS). EE during sleep was 15% higher
in patients than in controls (4.3770.10 vs. 3.8070.24 kJ/hour/kg FFM,
po0.05). The 24h-EE also tended to be higher in patients compared to
controls (þ8%, p¼0.057,158.3173.90 vs. 146.1374.35 kJ/day/kg FFM). No
signiﬁcant difference was observed between patients and controls for the
EE during walking at 4 or 5 km/h, during meals and at rest.
In conclusion, in kidney transplant patient weight gain occurs despite
hyper-metabolism during sleep and over 24 h. Mechanisms of weight gain
therefore possibly involve changes in food intake and/or spontaneous
physical activity.
http://dx.doi.org/10.1016/j.krcp.2012.04.34522
RELATIONS BETWEEN OBESITY AND RENAL OSTEODYSTROPHY:
REGULATION OF BONE METABOLISM BY LEPTIN.
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Recently, the bone tissue is now recognized as the protagonist in the
complex control mechanism energy because their hormone interactions
with the adipose tissue. Leptin is an adipokine and its production is
proportional to the amount of adipose tissue. Although leptin is associated
with obesity, and this is recognized as the protector of bone tissue, little
can be said about the inter-relationship in chronic kidney disease. In cross-
sectional study, 32 hemodialysis patients at Botucatu Medical School -
State University of Sao Paulo - Brazil, were evaluated anthropometrically
regarding the diagnosis of metabolic syndrome (based on the
harmonization of criteria IDF, AHA/NHLBI, ATP III), biochemically and bone
biopsy. Due to variability of serum leptin was applied also values of the
natural logarithm (Ln) of leptin corrected by BMI. In comparisons was used
Kruskal-Wallis, Pearson correlations were performed using regression
analysis and considered the Ln leptin / BMI as the dependent variable was
considered signiﬁcant with p value less than 5%. Positive correlations of
leptin have been shown in females (p¼0.006), body fat percentage (po0.001),
serum albumin (p¼0.035), and markers of metabolic syndrome, such as total
cholesterol (p¼0.01) , triglycerides (p¼0.02) basal insulin (p¼0.05) and BMI
(po0.001). About renal osteodystrophy, the sample has higher prevalence
(69%) of high turnover diseases - osteitis ﬁbrosa cystica and mixed bone
disease. BMI, percent body fat, leptin and Ln leptin/BMI showed no inﬂuence on
the bone turnover and osteoporosis. In regression analysis Ln leptin/BMI was
independently associated with age (p¼0.006) and individuals diagnosed with
metabolic syndrome (p¼0.002), histological classiﬁcations of bone tissue
showed no associations. In conclusion, this was a preliminary result which
reinforced the strong and independent relationship between leptin and
metabolic syndrome in chronic renal failure, however, has not found evidence
of the relationship between obesity, leptin and bone metabolism. Therefore, we
suggest that interferes with uremia anabolic effect of leptin on the bone,
